Results 101 to 110 of about 115,117 (314)

Psilocybin as a novel treatment for chronic pain

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey   +3 more
wiley   +1 more source

Somatostatin/somatostatin receptor signalling: Phosphotyrosine phosphatases [PDF]

open access: yesMolecular and Cellular Endocrinology, 2008
Activation of phosphotyrosine phosphatases (PTPs) by somatostatin receptor (SSTR) represents one of the main intracellular mechanisms involved in the antiproliferative effect of somatostatin (SST) and analogues. Since their molecular cloning, the role of PTPs is emerging as a major regulator of different cell functions including cell proliferation ...
openaire   +4 more sources

GPCR‐G protein signalling and its mutational landscape in cancer—Driver or passenger

open access: yesBritish Journal of Pharmacology, EarlyView.
G protein‐coupled receptors (GPCRs) play a crucial role in cellular signalling, regulating various physiological processes. Abnormal expression and mutations of GPCRs have been implicated in several types of cancer, influencing tumour initiation, progression and immune response.
Chenlin Feng   +3 more
wiley   +1 more source

Production and Quality Control of Indium-111 Pentetreotide Radiopharmaceutical in Iran [PDF]

open access: yesمجله علوم و فنون هسته‌ای, 2017
111In pentetreotide (OctreoScanTM) radiopharmaceutical is used extensively for the detection of a variety of cancers in medicine. Octerotide is a pharmaceutical with a structure similar to somatostatin which is administrated via intravenous injection in ...
S. Y Fazaeli Hoseini Nezhad, M Erfani
doaj  

Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. [PDF]

open access: green, 1979
Jan M. Lundberg   +8 more
openalex   +1 more source

Glucagonoma and Glucagonoma Syndrome: An Updated Review

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Background Glucagonoma is a rare well‐differentiated slowly proliferating pancreatic neuroendocrine tumour, characterized by several manifestations including necrolytic migratory erythema, weight loss, diabetes and anaemia. Aim The purpose of the current review was to acknowledge literature about this rare tumour discerning the clinical ...
Sofia Anelli   +8 more
wiley   +1 more source

Totalsynthese von Somatostatin-28 (Big-Somatostatin) / Total Synthesis of Somatostatin-28 (Big Somatostatin)

open access: yesZeitschrift für Naturforschung B, 1980
The total synthesis of the octacosapeptide corresponding to the proposed primary structure of porcine somatostatin-28, a possible precursor of somatostatin, is described. The primary structure of somatostatin-28 corresponds to that of somatostatin elongated at the N-terminus by a tetradecapeptide sequence.
Lucien Pradayrol   +6 more
openaire   +2 more sources

Erythematous Papules and Plaques in an Infant Receiving Glucagon Therapy

open access: yes
JEADV Clinical Practice, EarlyView.
Sara Al Janahi   +4 more
wiley   +1 more source

Autoimmunity in MASLD: Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
This review outlines the potential role of anti‐GPCR autoantibodies in MASLD/MASH, given their involvement in a wide range of diseases and their possible contribution to MASLD/MASH pathophysiology. We also focused on anti‐ApoA1 autoantibodies, sharing functional features with anti‐GPCR autoantibodies and have been shown to promote liver steatosis in ...
Sabrina Pagano   +3 more
wiley   +1 more source

Kussmaul's Sign Provoked by Intracardiac Metastasis of Endometrial Neuroendocrine Tumor

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yi‐Hsun Chen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy